Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of a meeting of the National Cancer Advisory Board (NCAB) and NCI Board of Scientific Advisors (BSA).

                    This will be a hybrid meeting held in-person and virtually and will be open to the public as indicated below. Individuals who plan to attend in-person or view the virtual meeting and need special assistance or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. The meeting can be accessed from the NIH Videocast at the following link:                     *https://videocast.nih.gov/​.*

A portion of the National Cancer Advisory Board meeting will be closed to the public in accordance with the provisions set forth in section 552b(c)(6), Title 5 U.S.C., as amended. The intramural programs and projects and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the intramural programs and projects, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         National Cancer Advisory Board.                    

*Date:*                         December 2, 2024.                    

*Open:*                         6:00 p.m. to 9:00 p.m.                    

*Agenda:*                         National Cancer Advisory Board Subcommittee Meetings.                    

*Place:*                         Gaithersburg Marriott Washingtonian Center, Room—TBD, 9751 Washington Boulevard, Gaithersburg, MD 20878 (In Person Meeting).                    

*Contact Person:*                         Paulette S. Gray, Ph.D., Director, Division of Extramural Activities, National Cancer Institute—Shady Grove, National Institutes of Health, 9609 Medical Center Drive, 7th Floor, Room. 7W444, Bethesda, MD 20892, 240-276-6340,                         *grayp@mail.nih.gov.*

*Name of Committee:*                         National Cancer Advisory Board.                    

*Date:*                         December 3, 2024.                    

*Closed:*                         8:00 a.m. to 8:45 a.m.                    

*Agenda:*                         Review of intramural program site visit outcomes and the discussion of confidential personnel issues.                    

*Place:*                         National Cancer Institute—Shady Grove, 9609 Medical Center Drive, Room TE406 & 408, Rockville, MD 20850 (In Person and Virtual Meeting).                    

*Contact Person:*                         Paulette S. Gray, Ph.D., Director, Division of Extramural Activities, National Cancer Institute—Shady Grove, National Institutes of Health, 9609 Medical Center Drive, 7th Floor, Room. 7W444, Bethesda, MD 20892 240-276-6340,                         *grayp@mail.nih.gov.*

*Name of Committee:*                         National Cancer Advisory Board and NCI Board of Scientific Advisors.                    

*Date:*                         December 3, 2024.                    

*Open:*                         9:00 a.m. to 4:00 p.m.                    

*Agenda:*                         Joint meeting of the National Cancer Advisory Board and NCI Board of Scientific Advisors, NCI Director's report and presentations, NCI Board of Scientific Advisors Concepts Review.                    

*Place:*                         National Cancer Institute—Shady Grove, 9609 Medical Center Drive, Room TE406 & 408, Rockville, MD 20850 (In Person and Virtual Meeting).                    

*Contact Person:*                         Paulette S. Gray, Ph.D., Director, Division of Extramural Activities, National Cancer Institute—Shady Grove, National Institutes of Health, 9609 Medical Center Drive, 7th Floor, Room 7W444, Bethesda, MD 20892 240-276-6340                         *grayp@mail.nih.gov.*

Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person.

In the interest of security, NIH has instituted stringent procedures for entrance onto the NCI-Shady Grove campus. All visitors will be asked to show one form of identification (for example, a government-issued photo ID, driver's license, or passport) and to state the purpose of their visit.

                        Information is also available on the Institute's/Center's home page: NCAB:                         *http://deainfo.nci.nih.gov/​advisory/​ncab/​ncab.htm,*                        BSA:                         *http://deainfo.nci.nih.gov/​advisory/​bsa/​bsa.htm,*                         where an agenda and any additional information for the meeting will be posted when available.                    

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS)

      ( print page 90025)    
Dated: November 7, 2024.

David W. Freeman, 

Supervisory Program Analyst Office of Federal Advisory Committee Policy.

[FR Doc. 2024-26430 Filed 11-13-24; 8:45 am]

BILLING CODE 4140-01-P